Pulmonary

Question 1

Pleural creatinine/plasma creatinine in urinothorax

Answer 1

> 1.7

Question 2

DPPi reduces exacerbation of brochiectasis

Answer 2

Brensocatib

Question 3

Pulmonary manifestation of CVID happens in 20-30% and respond well to rituximab/azathioprine

Answer 3

GLILD

granulomatous and lymphocytic ILD

Question 4

New recommendations for MAC infection

Answer 4

• using three drug regimen instead of two (azithromycin/Rifampicin/ethambutol)
• adding inhaled aminoglycoside amikacin for cavitory lesions
• duration until sputum comes negative, on average duration 15-18 months, minimum of 12 months.

Question 5

Trial for convalescent plasma

Answer 5

REMAP-CAP trial

Question 6

COVID19 entry is dependent on expression of these two host receptors

Answer 6

ACE2

TMPRSS2

Question 7

Corona RNA is recognized by this receptor on endosome

Answer 7

TLR7

Toll like Receptor 7

Question 8

What amino acid change in novel coronavirus

Answer 8

D614G

Question 9

UK new strain of COVID

Answer 9

B117

Question 10

Risk of hospitalization and mortality in patients with comorbidities compared to general population

Answer 10

Hospitalization 6x

Death 12x

Question 11

Monoclonal antibodies for mild to moderate COVID19

Answer 11

Bamlanivimab

Casirivimab/Imdevimab

Question 12

South Africa variant of COVID19

Answer 12

B1.351

Question 13

Check for pulmonary function in myasthenia

Answer 13

Vital capacity

NIF

Question 14

Fatal salicylate toxicity on lung

Answer 14

Non cardiac pulmonary edema

Question 15

Eye complications of OSA

Answer 15

Floppy iris syndrome